ReviewNeuropsychiatric disease and treatment2026
Targeting Programmed Cell Death in Depression: A Review of Traditional Chinese Medicine Interventions Based on Preclinical Evidence.
Review in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is a globally prevalent, highly disabling mental disorder, and its etiology, pathological mechanisms, and treatment approaches have long been a focus of intensive research. Programmed cell death (PCD) refers to a process in which cells actively undergo death to maintain internal homeostasis via specific signals or stimuli. Modern medical studies have demonstrated that the dysregulation of PCD modalities, including apoptosis, pyroptosis, autophagy, ferroptosis, necroptosis, and cuproptosis, is closely associated with the onset and progression of depression. Elucidating the molecular mechanisms of PCD in depression could provide critical insights for an in-depth understanding, prevention, and treatment of this disorder. In recent years, extensive research has been conducted in the field of traditional Chinese medicine (TCM) that targets PCD for depression treatment, yielding significant phased achievements. Therefore, this narrative review, covering literature primarily from the past decade, synthesizes preclinical evidence on six PCD modalities in depression. It further explores the potential mechanisms and current status of TCM interventions that target these PCD pathways, and discusses the crosstalk between them. By emphasizing mechanistic insights, this work aims to provide a theoretical foundation and guidance for future clinical prevention, treatment, and research on depression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.